RecruitingNot ApplicableNCT06447350

Alcohol Consumption: Norms, Identities, & Motivations

Alcohol Consumption: Norms, Identities, & Motivations (ADUC-Volet 3 " Prevention ")


Sponsor

University Hospital, Caen

Enrollment

240 participants

Start Date

Apr 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The emergence of new problematic alcohol consumption practices among young people requires new dynamics in prevention strategies. In this context, the ADUC project (Alcohol and Drugs at the University of Caen) aims to develop a better understanding of alcohol consumption, and in particular the practice of binge drinking (BD), in order to develop relevant and adapted prevention tools. The ALCONIM study (IRESP funding; Agreement 20II31-00 - ADUC part 3) is a randomized controlled trial that focuses on the specific determinants of norms, identities and motivations. The main objective of this experiment in social psychology is to validate a program for the prevention of BD practices based on motivational interviewing (MI) associated with induced hypocrisy (IH), social identity mapping (SIM) and motivational modeling (MM) in a student environment.


Eligibility

Min Age: 18 YearsMax Age: 30 Years

Inclusion Criteria5

  • aged between 18 and 30 years old,
  • of French mother language,
  • of both sexes,
  • binge drinking score > 1,
  • having signed an informed consent.

Exclusion Criteria2

  • Pregnant or breastfeeding students,
  • students who declare a history of neurological, neurosurgical, psychiatric, endocrine or infectious diseases.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALInduced hypocrisy

Induced hypocrisy task

BEHAVIORALsocial identity mapping

Social identity mapping task

BEHAVIORALMotivational modeling

Motivational modeling task

BEHAVIORALmotivational interviewing

motivational interviewing


Locations(1)

CAEN University Hospital

Caen, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06447350


Related Trials